FibroGen Inc

NASDAQ:FGEN   4:00:00 PM EDT
16.48
+1.44 (+9.57%)
4:40:22 PM EDT: $15.65 -0.83 (-5.04%)
Earnings Announcements

Fibrogen Inc Reports Q3 Loss Per Share Of $0.98

Published: 11/07/2022 22:05 GMT
FibroGen Inc (FGEN) - Fibrogen Reports Third Quarter 2022 Financial Results.
Total Revenue for Q3 of 2022 Was $15.7 Million, As Compared to $156.0 Million.
Q3 Loss per Share $0.98.
Announced a Non-dilutive Royalty Monetization Transaction With Novaquest Capital Management.
Anticipate 2022 Ending Cash Balance to Be $380-$410 Million.
Q3 Earnings per Share View $-0.81 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $27.95 Million
Adjusted EPS is expected to be -$0.81

Next Quarter Revenue Guidance is expected to be $29.29 Million
Next Quarter EPS Guidance is expected to be -$0.85

More details on our Analysts Page.